Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Medchemexpress LLC 4-acetamido-N-(tert-butyl)benzamide | 183619-38-7 | 99.8% | 234.29 | C13H18N2O2 | 10 MG
Supplier: Medchemexpress LLC HY10037610MG
CPI-1189 is a small-molecule TNF-α release inhibitor used in preclinical research to investigate inflammatory and neuroprotective mechanisms. It has been reported to inhibit p38 phosphorylation and reduce apoptosis in cellular models, making it useful for studies of neurodegeneration, HIV-related neuronal injury, and oxidative stress.
- Orally active TNF-α release inhibitor suitable for cell-based assays.
- Modulates p38 signaling to reduce inflammation-related apoptosis.
- High chemical purity for reproducible experimental results.
- Available in small-scale quantities for research applications.
- Supplied with datasheet listing CAS, molecular weight, and structural identifiers.
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?